134 related articles for article (PubMed ID: 21319228)
1. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.
Wang J; Che YL; Li G; Liu B; Shen TM; Wang H; Linghu H
Mol Carcinog; 2011 Jul; 50(7):506-15. PubMed ID: 21319228
[TBL] [Abstract][Full Text] [Related]
2. Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Han L
Tumour Biol; 2015 Feb; 36(2):915-9. PubMed ID: 25307974
[TBL] [Abstract][Full Text] [Related]
3. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Yang X
Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
[TBL] [Abstract][Full Text] [Related]
4. Essential roles of Crk and CrkL in fibroblast structure and motility.
Park TJ; Curran T
Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
Park T; Koptyra M; Curran T
J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
[TBL] [Abstract][Full Text] [Related]
6. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.
Heikkinen LS; Kazlauskas A; Melén K; Wagner R; Ziegler T; Julkunen I; Saksela K
J Biol Chem; 2008 Feb; 283(9):5719-27. PubMed ID: 18165234
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
Park T; Large N; Curran T
J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
[TBL] [Abstract][Full Text] [Related]
8. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
9. Crk and CrkL are required for cell transformation by v-fos and v-ras.
Koptyra M; Park TJ; Curran T
Mol Carcinog; 2016 Jan; 55(1):97-104. PubMed ID: 25557916
[TBL] [Abstract][Full Text] [Related]
10. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
11. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
Antoku S; Mayer BJ
J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
[TBL] [Abstract][Full Text] [Related]
13. Interplay of the proto-oncogene proteins CrkL and CrkII in insulin-like growth factor-I receptor-mediated signal transduction.
Koval AP; Karas M; Zick Y; LeRoith D
J Biol Chem; 1998 Jun; 273(24):14780-7. PubMed ID: 9614078
[TBL] [Abstract][Full Text] [Related]
14. Crk and CrkL as Therapeutic Targets for Cancer Treatment.
Park T
Cells; 2021 Mar; 10(4):. PubMed ID: 33801580
[TBL] [Abstract][Full Text] [Related]
15. The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins.
Oehrl W; Kardinal C; Ruf S; Adermann K; Groffen J; Feng GS; Blenis J; Tan TH; Feller SM
Oncogene; 1998 Oct; 17(15):1893-901. PubMed ID: 9788432
[TBL] [Abstract][Full Text] [Related]
16. Requirement for Crk and CrkL during postnatal lens development.
Park T; Curran T
Biochem Biophys Res Commun; 2020 Aug; 529(3):603-607. PubMed ID: 32736680
[TBL] [Abstract][Full Text] [Related]
17. Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.
Jankowski W; Saleh T; Pai MT; Sriram G; Birge RB; Kalodimos CG
Nat Chem Biol; 2012 May; 8(6):590-6. PubMed ID: 22581121
[TBL] [Abstract][Full Text] [Related]
18. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
Sanders MA; Ampasala D; Basson MD
J Biol Chem; 2009 Jan; 284(1):27-35. PubMed ID: 19004829
[TBL] [Abstract][Full Text] [Related]
19. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
[TBL] [Abstract][Full Text] [Related]
20. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways.
Feller SM; Knudsen B; Hanafusa H
Oncogene; 1995 Apr; 10(8):1465-73. PubMed ID: 7731701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
